Home / US Department of Health and Human Services / CDC-RFA-JG-26-0178

Strengthening Ghana Health Service laboratory services, diagnostic networks, and systems for a more effective, efficient, and sustainable response to HIV, TB, and other priority health threats

Open now · Cooperative Agreement · CDC-RFA-JG-26-0178

Check my fit, free Open the official call ↗

Next cut-off

16 Oct '26

in 40 days

Call budget

across every grant here

Grants expected

projects that will be funded

Funding rate

not published, read the conditions

What this call funds

The Award Ceiling for Year 1 is 0 (none). CDC anticipates an Approximate Total Fiscal Year Funding amount of $500,000 for Year 1, subject to the availability of funds.This NOFO provides operational support through financial and technical resources to the Ghana Health Service (GHS)/Ministry of Health (MoH). The goal is to help them coordinate and improve laboratory capacity so they can deliver high-quality, efficient services for HIV, TB, and other priority health areas. This NOFO will advance HIV testing, treatment, retention, and viral suppression in Ghana by:Equipping laboratories with appropriate diagnostic technologies.Building staff skills to manage quality laboratory services.Strengthening the capacity of the Government of Ghana (GoG) MoH to take full responsibility for managing laboratory services, diagnostic networks, and systems for HIV, TB, and other priority infectious diseases.

What applying costs you

Item	Estimate	Note
Drafting effort	3–4 weeks	single submission
Time to first payment	6–9 months	cut-off → evaluation → grant agreement

These are Bemzu's estimates from the call's structure (the number of stages and whether a consortium is required) not figures published by the Commission. Only the co-financing share is read from the call itself.

Also open in HHS

CallNext cut-offPer grant

Cellular and Molecular Biology of Complex Brain Disorders (R01 Clinical Trial Not Allowed)PAR-25-038 · US Department of Health and Human Services · single applicant* 07 Sept '26in 1d , not published Alcohol Treatment, Pharmacotherapy, and Recovery Research (R34 Clinical Trial required)PAR-25-193 · US Department of Health and Human Services · single applicant* 07 Sept '26in 1d , not published Social disconnection and Suicide Risk in Late Life (R21 Clinical Trial Optional)PAR-25-066 · US Department of Health and Human Services · single applicant* 07 Sept '26in 1d , not published Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia (R21 Clinical Trial Optional)PAR-25-064 · US Department of Health and Human Services · single applicant* 07 Sept '26in 1d , not published Schizophrenia and related disorders during mid- to late-life (R01 Clinical Trial Optional)PAR-25-039 · US Department of Health and Human Services · single applicant* 07 Sept '26in 1d , not published

Become the beneficiary.

Eight questions, no account, nothing sent anywhere. You will know which of the 1526 open calls you can actually enter before you finish your coffee.

Check my fit